Expression and the role of myeloid-derived suppressor cells in the peripheral blood in patients with chronic hepatitis B

被引：0
|
作者：
陆丽蓉 [1 ]
机构：
[1] Dept Infect Dis,3rd Affil Hosp,SunYat-sen
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2014年 / 31卷 / 02期
关键词：
CHB; Expression and the role of myeloid-derived suppressor cells in the peripheral blood in patients with chronic hepatitis B; MDSC;
D O I：
暂无
中图分类号：
R512.62 [];
学科分类号：
摘要：
Objective To investigate the correlation between the frequency of myeloid-derived suppressor cells(MDSC)and the frequency of regulatory T cells(Treg)in the peripheral blood in patients with chronic hepatitis B(CHB)and its clinical significance.Methods A total of 45 CHB patients including 23 mild-to-moderate CHB patients,22severe CHB patients,and 15 healhy control cytometry
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [1] Expression and significance of peripheral myeloid-derived suppressor cells in chronic hepatitis B patients
    Lv, Y.
    Cui, M.
    Lv, Z.
    Lu, J.
    Zhang, X.
    Zhao, Z.
    Wang, Y.
    Gao, L.
    Tsuji, N. M.
    Yan, H.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (05) : 462 - 469
  • [2] Role of myeloid-derived suppressor cells in chronic brucellosis
    Hou, Shuiping
    Kong, Fandong
    Li, Xintong
    Xu, Yanwen
    Chen, Shouyi
    Zhang, Sheng
    Zhang, Ling
    Li, Tingting
    Fu, Yongshui
    Li, Chengyao
    Wang, Wenjing
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [3] The possible role and clinical implication of myeloid-derived suppressor cells in the peripheral blood of patients with hepatitis B virus-related acute-on-chronic liver failure
    曾映夫
    ChinaMedicalAbstracts(InternalMedicine), 2016, 33 (03) : 171 - 172
  • [4] Granulocytic myeloid-derived suppressor cells in peripheral blood of patients with cutaneous melanoma
    Franklin, Cindy
    Schilling, Bastian
    INTERNATIONAL IMMUNOLOGY, 2016, 28 (02) : 99 - 99
  • [5] Characterization of myeloid-derived suppressor cells in the peripheral blood and bone marrow of patients with chronic idiopathic neutropenia
    Bizymi, Nikoleta
    Damianaki, Athina
    Aresti, Nikoletta
    Karasachinidis, Anastasios
    Vlata, Zacharenia
    Lavigne, Matthieu
    Dialynas, Emmanuel
    Gounalaki, Niki
    Stratidaki, Irene
    Tsaknakis, Grigorios
    Batsali, Aristea
    Mavroudi, Irene
    Velegraki, Maria
    Sperelakis, Ioannis
    Pontikoglou, Charalampos
    Verginis, Panayotis
    Papadaki, Helen A.
    HEMASPHERE, 2024, 8 (09):
  • [6] Expression and Clinical Significance of Myeloid Derived Suppressor Cells in Chronic Hepatitis B Patients
    Lu, Li-Rong
    Liu, Jing
    Xu, Zhen
    Zhang, Geng-Lin
    Li, De-Chang
    Lin, Chao-Shuang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (10) : 4367 - 4372
  • [7] MYELOID-DERIVED SUPPRESSOR CELLS (MDSCS) IN THE PERIPHERAL BLOOD OF CHRONIC HEPATITIS C PATIENTS AFTER 4 WEEKS OF PEG-INTERFERON
    Lin, C. S.
    She, L. H.
    Wu, Z. B.
    Zhang, X. H.
    Zhao, Z. X.
    Gao, Z. L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S334 - S334
  • [8] ADVANCED NSCLC: PROGNOSTIC ROLE OF THE EXPRESSION OF MYELOID-DERIVED SUPPRESSOR CELLS RELATED MARKERS IN PERIPHERAL BLOOD SAMPLES
    Caballero, Elena
    Artigot, Aida
    Sanmartin, Elena
    Uso, Marta
    Gallach, Sandra
    Sirera, Rafael
    Rosell, Rafael
    Camps, Carlos
    Jantus Lewintre, Eloisa
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S998 - S999
  • [9] The role of myeloid-derived suppressor cells in chronic airway inflammation
    Horie, Ichiro
    Isohama, Yoichiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S50 - S50
  • [10] The Clonality of Myeloid-Derived Suppressor Cells in Chronic Myeloid Leukemia Patients
    Kulemina, Olga
    Chitanava, Tamara
    Vlasik, Roman
    Khordzhasov, Leonid
    Nikulina, Tatiana
    Merzlikina, Olga
    Mirolubova, Yulia
    Tolstopyatova, Elena
    Solovyev, Vyacheslav
    Shnalieva, Nadezhda
    Butylin, Pavel
    Luchkina, Nadezhda
    Ataman, Alexander
    Aronov, Alexey
    Lomaia, Elza
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S344 - S344
12345